Piperazine derivatives as iron chelators: a potential application in neurobiology.
Identifieur interne : 000242 ( PubMed/Corpus ); précédent : 000241; suivant : 000243Piperazine derivatives as iron chelators: a potential application in neurobiology.
Auteurs : S. Abdelsayed ; N T Ha Duong ; C. Bureau ; P P Michel ; E C Hirsch ; J M El Hage Chahine ; N. SerradjiSource :
- Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine [ 1572-8773 ] ; 2015.
English descriptors
- KwdEn :
- Animals, Chlorides (antagonists & inhibitors), Chlorides (pharmacology), Dopaminergic Neurons (cytology), Dopaminergic Neurons (drug effects), Dopaminergic Neurons (metabolism), Embryo, Mammalian, Ferric Compounds (antagonists & inhibitors), Ferric Compounds (pharmacology), Hydrogen-Ion Concentration, Iron Chelating Agents (chemical synthesis), Iron Chelating Agents (pharmacology), Kinetics, Mesencephalon (cytology), Mesencephalon (drug effects), Mesencephalon (metabolism), Neuroprotective Agents (chemical synthesis), Neuroprotective Agents (pharmacology), Piperazines (chemical synthesis), Piperazines (pharmacology), Primary Cell Culture, Rats, Rats, Wistar, Thermodynamics.
- MESH :
- chemical , antagonists & inhibitors : Chlorides, Ferric Compounds.
- chemical , chemical synthesis : Iron Chelating Agents, Neuroprotective Agents, Piperazines.
- chemical , pharmacology : Chlorides, Ferric Compounds, Iron Chelating Agents, Neuroprotective Agents, Piperazines.
- cytology : Dopaminergic Neurons, Mesencephalon.
- drug effects : Dopaminergic Neurons, Mesencephalon.
- metabolism : Dopaminergic Neurons, Mesencephalon.
- Animals, Embryo, Mammalian, Hydrogen-Ion Concentration, Kinetics, Primary Cell Culture, Rats, Rats, Wistar, Thermodynamics.
Abstract
Polysubstituted piperazine derivatives, designed as new iron chelators, were synthesized and fully characterized by nuclear magnetic resonance and mass spectroscopy. Their potential to prevent iron-induced neurotoxicity was assessed using a cellular model of Parkinson disease. We demonstrated their ability to provide sustained neuroprotection to dopaminergic neurons that are vulnerable in this pathology. The iron chelating properties of the new compounds were determined by spectrophotometric titration illustrating that high affinity for iron is not associated with important neuroprotective effects.
DOI: 10.1007/s10534-015-9889-x
PubMed: 26502356
Links to Exploration step
pubmed:26502356Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Piperazine derivatives as iron chelators: a potential application in neurobiology.</title><author><name sortKey="Abdelsayed, S" sort="Abdelsayed, S" uniqKey="Abdelsayed S" first="S" last="Abdelsayed">S. Abdelsayed</name><affiliation><nlm:affiliation>Univ Paris Diderot, Sorbonne Paris Cite, ITODYS, UMR 7086, CNRS, 15 rue Jean-Antoine de Baıf, 75205 Paris Cedex 13, France</nlm:affiliation></affiliation></author><author><name sortKey="Duong, N T Ha" sort="Duong, N T Ha" uniqKey="Duong N" first="N T Ha" last="Duong">N T Ha Duong</name></author><author><name sortKey="Bureau, C" sort="Bureau, C" uniqKey="Bureau C" first="C" last="Bureau">C. Bureau</name></author><author><name sortKey="Michel, P P" sort="Michel, P P" uniqKey="Michel P" first="P P" last="Michel">P P Michel</name></author><author><name sortKey="Hirsch, E C" sort="Hirsch, E C" uniqKey="Hirsch E" first="E C" last="Hirsch">E C Hirsch</name></author><author><name sortKey="Chahine, J M El Hage" sort="Chahine, J M El Hage" uniqKey="Chahine J" first="J M El Hage" last="Chahine">J M El Hage Chahine</name></author><author><name sortKey="Serradji, N" sort="Serradji, N" uniqKey="Serradji N" first="N" last="Serradji">N. Serradji</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26502356</idno><idno type="pmid">26502356</idno><idno type="doi">10.1007/s10534-015-9889-x</idno><idno type="wicri:Area/PubMed/Corpus">000242</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000242</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Piperazine derivatives as iron chelators: a potential application in neurobiology.</title><author><name sortKey="Abdelsayed, S" sort="Abdelsayed, S" uniqKey="Abdelsayed S" first="S" last="Abdelsayed">S. Abdelsayed</name><affiliation><nlm:affiliation>Univ Paris Diderot, Sorbonne Paris Cite, ITODYS, UMR 7086, CNRS, 15 rue Jean-Antoine de Baıf, 75205 Paris Cedex 13, France</nlm:affiliation></affiliation></author><author><name sortKey="Duong, N T Ha" sort="Duong, N T Ha" uniqKey="Duong N" first="N T Ha" last="Duong">N T Ha Duong</name></author><author><name sortKey="Bureau, C" sort="Bureau, C" uniqKey="Bureau C" first="C" last="Bureau">C. Bureau</name></author><author><name sortKey="Michel, P P" sort="Michel, P P" uniqKey="Michel P" first="P P" last="Michel">P P Michel</name></author><author><name sortKey="Hirsch, E C" sort="Hirsch, E C" uniqKey="Hirsch E" first="E C" last="Hirsch">E C Hirsch</name></author><author><name sortKey="Chahine, J M El Hage" sort="Chahine, J M El Hage" uniqKey="Chahine J" first="J M El Hage" last="Chahine">J M El Hage Chahine</name></author><author><name sortKey="Serradji, N" sort="Serradji, N" uniqKey="Serradji N" first="N" last="Serradji">N. Serradji</name></author></analytic><series><title level="j">Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine</title><idno type="eISSN">1572-8773</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Chlorides (antagonists & inhibitors)</term><term>Chlorides (pharmacology)</term><term>Dopaminergic Neurons (cytology)</term><term>Dopaminergic Neurons (drug effects)</term><term>Dopaminergic Neurons (metabolism)</term><term>Embryo, Mammalian</term><term>Ferric Compounds (antagonists & inhibitors)</term><term>Ferric Compounds (pharmacology)</term><term>Hydrogen-Ion Concentration</term><term>Iron Chelating Agents (chemical synthesis)</term><term>Iron Chelating Agents (pharmacology)</term><term>Kinetics</term><term>Mesencephalon (cytology)</term><term>Mesencephalon (drug effects)</term><term>Mesencephalon (metabolism)</term><term>Neuroprotective Agents (chemical synthesis)</term><term>Neuroprotective Agents (pharmacology)</term><term>Piperazines (chemical synthesis)</term><term>Piperazines (pharmacology)</term><term>Primary Cell Culture</term><term>Rats</term><term>Rats, Wistar</term><term>Thermodynamics</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Chlorides</term><term>Ferric Compounds</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Iron Chelating Agents</term><term>Neuroprotective Agents</term><term>Piperazines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Chlorides</term><term>Ferric Compounds</term><term>Iron Chelating Agents</term><term>Neuroprotective Agents</term><term>Piperazines</term></keywords><keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>Dopaminergic Neurons</term><term>Mesencephalon</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Dopaminergic Neurons</term><term>Mesencephalon</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Dopaminergic Neurons</term><term>Mesencephalon</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Embryo, Mammalian</term><term>Hydrogen-Ion Concentration</term><term>Kinetics</term><term>Primary Cell Culture</term><term>Rats</term><term>Rats, Wistar</term><term>Thermodynamics</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Polysubstituted piperazine derivatives, designed as new iron chelators, were synthesized and fully characterized by nuclear magnetic resonance and mass spectroscopy. Their potential to prevent iron-induced neurotoxicity was assessed using a cellular model of Parkinson disease. We demonstrated their ability to provide sustained neuroprotection to dopaminergic neurons that are vulnerable in this pathology. The iron chelating properties of the new compounds were determined by spectrophotometric titration illustrating that high affinity for iron is not associated with important neuroprotective effects.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26502356</PMID><DateCreated><Year>2016</Year><Month>02</Month><Day>06</Day></DateCreated><DateCompleted><Year>2016</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2016</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1572-8773</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine</Title><ISOAbbreviation>Biometals</ISOAbbreviation></Journal><ArticleTitle>Piperazine derivatives as iron chelators: a potential application in neurobiology.</ArticleTitle><Pagination><MedlinePgn>1043-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10534-015-9889-x</ELocationID><Abstract><AbstractText>Polysubstituted piperazine derivatives, designed as new iron chelators, were synthesized and fully characterized by nuclear magnetic resonance and mass spectroscopy. Their potential to prevent iron-induced neurotoxicity was assessed using a cellular model of Parkinson disease. We demonstrated their ability to provide sustained neuroprotection to dopaminergic neurons that are vulnerable in this pathology. The iron chelating properties of the new compounds were determined by spectrophotometric titration illustrating that high affinity for iron is not associated with important neuroprotective effects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abdelsayed</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Univ Paris Diderot, Sorbonne Paris Cite, ITODYS, UMR 7086, CNRS, 15 rue Jean-Antoine de Baıf, 75205 Paris Cedex 13, France</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duong</LastName><ForeName>N T Ha</ForeName><Initials>NT</Initials></Author><Author ValidYN="Y"><LastName>Bureau</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Michel</LastName><ForeName>P P</ForeName><Initials>PP</Initials></Author><Author ValidYN="Y"><LastName>Hirsch</LastName><ForeName>E C</ForeName><Initials>EC</Initials></Author><Author ValidYN="Y"><LastName>Chahine</LastName><ForeName>J M El Hage</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Serradji</LastName><ForeName>N</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Biometals</MedlineTA><NlmUniqueID>9208478</NlmUniqueID><ISSNLinking>0966-0844</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002712">Chlorides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005290">Ferric Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007502">Iron Chelating Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010879">Piperazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>U38V3ZVV3V</RegistryNumber><NameOfSubstance UI="C024555">ferric chloride</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002712" MajorTopicYN="N">Chlorides</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059290" MajorTopicYN="N">Dopaminergic Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004622" MajorTopicYN="N">Embryo, Mammalian</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005290" MajorTopicYN="N">Ferric Compounds</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007502" MajorTopicYN="N">Iron Chelating Agents</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008636" MajorTopicYN="N">Mesencephalon</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010879" MajorTopicYN="N">Piperazines</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061251" MajorTopicYN="N">Primary Cell Culture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013816" MajorTopicYN="N">Thermodynamics</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>07</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26502356</ArticleId><ArticleId IdType="doi">10.1007/s10534-015-9889-x</ArticleId><ArticleId IdType="pii">10.1007/s10534-015-9889-x</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000242 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000242 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:26502356
|texte= Piperazine derivatives as iron chelators: a potential application in neurobiology.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26502356" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |